↓ Skip to main content

Evaluation of patients’ expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index – the benefica study

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, February 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evaluation of patients’ expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index – the benefica study
Published in
Allergy, Asthma & Clinical Immunology, February 2015
DOI 10.1186/s13223-015-0073-1
Pubmed ID
Authors

Pascal Demoly, Michel Aubier, Frédéric de Blay, François Wessel, Pierre Clerson, Pascal Maigret

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 4%
Switzerland 1 4%
Unknown 25 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 19%
Student > Ph. D. Student 4 15%
Other 4 15%
Librarian 2 7%
Student > Doctoral Student 1 4%
Other 5 19%
Unknown 6 22%
Readers by discipline Count As %
Medicine and Dentistry 12 44%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Agricultural and Biological Sciences 2 7%
Immunology and Microbiology 1 4%
Unspecified 1 4%
Other 2 7%
Unknown 7 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2015.
All research outputs
#17,302,400
of 25,394,764 outputs
Outputs from Allergy, Asthma & Clinical Immunology
#668
of 925 outputs
Outputs of similar age
#163,424
of 270,256 outputs
Outputs of similar age from Allergy, Asthma & Clinical Immunology
#10
of 12 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 925 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.8. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 270,256 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.